Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Manipulation of DNA Repair Proficiency in Mouse Models of Colorectal Cancer.

Mcilhatton MA, Boivin GP, Groden J.

Biomed Res Int. 2016;2016:1414383. doi: 10.1155/2016/1414383. Epub 2016 Jun 20. Review.

2.

Analgesic use and the risk of primary adult brain tumor.

Egan KM, Nabors LB, Thompson ZJ, Rozmeski CM, Anic GA, Olson JJ, LaRocca RV, Chowdhary SA, Forsyth PA, Thompson RC.

Eur J Epidemiol. 2016 Sep;31(9):917-25. doi: 10.1007/s10654-016-0129-7. Epub 2016 Feb 19.

PMID:
26894804
3.

Mouse models of DNA mismatch repair in cancer research.

Lee K, Tosti E, Edelmann W.

DNA Repair (Amst). 2016 Feb;38:140-6. doi: 10.1016/j.dnarep.2015.11.015. Epub 2015 Dec 4. Review.

4.

Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.

Kortüm B, Campregher C, Lang M, Khare V, Pinter M, Evstatiev R, Schmid G, Mittlböck M, Scharl T, Kucherlapati MH, Edelmann W, Gasche C.

Gut. 2015 Dec;64(12):1905-12. doi: 10.1136/gutjnl-2014-307663. Epub 2014 Nov 26.

5.

Effects of aspirin on colorectal cancer related to lynch syndrome.

Beck SL.

J Adv Pract Oncol. 2012 Nov;3(6):395-8. Review.

6.

Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer.

Stolfi C, De Simone V, Pallone F, Monteleone G.

Int J Mol Sci. 2013 Sep 3;14(9):17972-85. doi: 10.3390/ijms140917972. Review.

7.

Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention.

Battaglia V, DeStefano Shields C, Murray-Stewart T, Casero RA Jr.

Amino Acids. 2014 Mar;46(3):511-9. doi: 10.1007/s00726-013-1529-6. Epub 2013 Jun 15. Review.

8.

Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?

Manzano A, Pérez-Segura P.

ScientificWorldJournal. 2012;2012:327341. doi: 10.1100/2012/327341. Epub 2012 Apr 29. Review.

9.

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans DG, Maher ER, Bertario L, Bisgaard ML, Dunlop MG, Ho JW, Hodgson SV, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen HF, Barker G, Crawford G, Elliott F, Movahedi M, Pylvanainen K, Wijnen JT, Fodde R, Lynch HT, Mathers JC, Bishop DT; CAPP2 Investigators.

Lancet. 2011 Dec 17;378(9809):2081-7. doi: 10.1016/S0140-6736(11)61049-0. Epub 2011 Oct 27.

10.

Aspirin for prevention of cancer and cardiovascular disease.

Rose PW, Watson EK, Jenkins LS.

Br J Gen Pract. 2011 Jun;61(587):412-5. doi: 10.3399/bjgp11X578133. No abstract available.

11.

Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse model.

McIlhatton MA, Tyler J, Kerepesi LA, Bocker-Edmonston T, Kucherlapati MH, Edelmann W, Kucherlapati R, Kopelovich L, Fishel R.

Cancer Prev Res (Phila). 2011 May;4(5):684-93. doi: 10.1158/1940-6207.CAPR-10-0319. Epub 2011 Mar 24.

12.

PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.

Baba Y, Nosho K, Shima K, Goessling W, Chan AT, Ng K, Chan JA, Giovannucci EL, Fuchs CS, Ogino S.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):822-31. doi: 10.1158/1055-9965.EPI-09-1154. Epub 2010 Mar 3.

13.

Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeats.

Campregher C, Honeder C, Chung H, Carethers JM, Gasche C.

Clin Cancer Res. 2010 Mar 15;16(6):1950-6. doi: 10.1158/1078-0432.CCR-09-2854. Epub 2010 Mar 2.

14.

Role of MutS homolog 2 (MSH2) in intestinal myofibroblast proliferation during Crohn's disease stricture formation.

Floer M, Binion DG, Nelson VM, Manley S, Wellner M, Sadeghi S, Behmaram B, Sewell C, Otterson MF, Kucharzik T, Rafiee P.

Am J Physiol Gastrointest Liver Physiol. 2008 Sep;295(3):G581-90. doi: 10.1152/ajpgi.90311.2008. Epub 2008 Jul 17.

16.

Chemically induced increases and decreases in the rate of expansion of a CAG*CTG triplet repeat.

Gomes-Pereira M, Monckton DG.

Nucleic Acids Res. 2004 May 20;32(9):2865-72. Print 2004.

17.

Aspirin induces apoptosis through release of cytochrome c from mitochondria.

Zimmermann KC, Waterhouse NJ, Goldstein JC, Schuler M, Green DR.

Neoplasia. 2000 Nov-Dec;2(6):505-13.

18.

Genetic susceptibility to non-polyposis colorectal cancer.

Lynch HT, de la Chapelle A.

J Med Genet. 1999 Nov;36(11):801-18. Review.

19.

Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1.

Wheeler JM, Beck NE, Kim HC, Tomlinson IP, Mortensen NJ, Bodmer WF.

Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10296-301.

20.

Supplemental Content

Support Center